Cargando…
Caspase Cleaved Tau in Alzheimer’s Disease: A Therapeutic Target Realized
Autor principal: | Rohn, Troy T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4308811/ https://www.ncbi.nlm.nih.gov/pubmed/25639474 |
Ejemplares similares
-
Caspase-Cleaved Tau Co-Localizes with Early Tangle Markers in the Human Vascular Dementia Brain
por: Day, Ryan J., et al.
Publicado: (2015) -
Activation of the Nrf2 Pathway Prevents Mitochondrial Dysfunction Induced by Caspase-3 Cleaved Tau: Implications for Alzheimer’s Disease
por: Villavicencio-Tejo, Francisca, et al.
Publicado: (2022) -
A driver or a passenger? D421-caspase cleaved tau is associated with aggregated and insoluble tau
por: Gibson, Yolanda, et al.
Publicado: (2013) -
Caspase-6-cleaved Tau fails to induce Tau hyperphosphorylation and aggregation, neurodegeneration, glial inflammation, and cognitive deficits
por: Noël, Anastasia, et al.
Publicado: (2021) -
Caspase-3 and Caspase-6 cleave STAT1 in leukemic cells
por: Licht, Verena, et al.
Publicado: (2014)